A Leading BioMedical Company
Our company is driven by science-based research and focussed on the development, processing and manufacturing of high-quality cannabinoid products. We provide a diverse range of goods that not only include medicinals, nutraceuticals and cosmetics, but food, beverage and veterinary products as well. We derive all our products from natural cannabis and hemp using a state-of-the-art process that is as close to the source as possible. We are proud to sport a diverse team of world-class talent in the fields of education, research, evidence-based product development, GMP manufacturing, quality production and packaging with the most extensive access to patients and international markets. Research for developing new formulations and methods of delivery along with providing best practices educations are the highlights of our team.
Board of Directors
Ommid John Faghani
CHAIRMAN OF THE BOARD
CHIEF EXECUTIVE OFFICER
INTERIM CHIEF FINANCIAL OFFICER
Ommid John Faghani has been involved in various businesses in Canada and overseas including manufacturing, pharmaceutical, finance, telemedicine, education, and immigration.
He is the President of Newland Financial Inc. a private lending and Investment company in Toronto. Newland provides business loans for start-ups and construction financing
He also has been the Managing Director of Canadian Consulting Group Inc. since 1997 assisting hundreds of entrepreneurs and investors with their migration and investment needs in Canada. He is the President of Iran Canada Business Council and a Director and Board member for MTCC 788 in Toronto.
He has studied engineering, Sciences and management at McMaster, U of T and Ryerson. He holds a degree in Engineering, an MBA, MSc in Strategic Planning and currently doing a Doctoral degree in Management. OJ has been an instructor in several universities and is involved in charities and community organizations.
BOARD OF DIRECTORS
Proven record for building startup companies into national successes. Chairman of MAJIC Development Group LLC. Involved in $100 million development projects, construction for many Fortune 500 clients and retailers. Experience in business development consulting, biotech industry consulting, and a diverse mix of independent business ventures: residential and commercial property ownership, restaurants, state mortgage banking enterprise, ship salvaging/dismantling, hotels, security services, magazine publishing, and alcohol/non-alcoholic import and export.
BOARD OF DIRECTORS
CORPORATE LEGAL COUNSEL
Partner at TingleMerrett LLP law firm. Corporate and securities counsel to numerous Canadian and International public and private corporations, including a large number of issuers active in the North American cannabis industry. Wide experience in private and public debt and equity offerings, corporate acquisitions of both assets and shares, corporate structuring and debt financing. Extensive experience assisting issuers intending to list and operate on Canadian stock exchanges. BA of Commerce and BA of Laws, University of Alberta. Executive member of the Advisory Board, TSX Venture Exchange.
Dr. Kaivan Talachian
BOARD OF DIRECTORS
Dr. Kaivan Talachian holds a doctorate in pharmacy (Pharm. D) and is a practicing pharmacist in Canada with more than 25 years of diverse experience in the pharmaceutical, medical devices, and healthcare information technology.
He has been involved in medical cannabis research, education, and innovation since 2013. Kaivan managed the development and implementation of integrated medication management and nursing medication verification solution which was pioneered at West Park hospital in Toronto. This solution was subsequently implemented in the United States and acquired by Baxter Pharmaceuticals. He has contributed to the application of several patents in Canada, the US, and the European Union.
He is currently the CEO of Concinto Inc, a consulting firm based in Toronto as well as the executive director of Hami Canada a not for profit organization focused on providing educational opportunities in deprived global regions.